Cardiovascular Safety of Medication Treatments for 198 Attention-Deficit/Hyperactivity Disorder

被引：2

作者：

Newcorn, Jeffrey H. ^{[1
]}

Donnelly, Craig ^{[2
]}

机构：

[1] Mt Sinai Sch Med, New York, NY USA

[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA

来源：

MOUNT SINAI JOURNAL OF MEDICINE | 2009年 / 76卷 / 02期

关键词：

CONGENITAL CARDIAC DEFECTS; AMERICAN-HEART-ASSOCIATION; STIMULANT-DRUGS; ADOLESCENTS; STATEMENT; COMMITTEE; CHILDREN; COUNCIL; DISEASE; YOUNG;

D O I：

10.1002/msj.20096

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：198 / 203

页数：6

共 13 条

[1]

American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD, 2008, J DEV BEHAV PEDIAT, V29, P335

[2]

BAUCHNER H, 2008, J WATCH PEDIAT ADOLE

[3] Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community [J].

Biederman, J ;

Faraone, SV ;

Spencer, TJ ;

Mick, E ;

Monuteaux, MC ;

Aleardi, M .

JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (04) :524-540

[4] Cardiovascular monitoring of children and adolescents receiving psychotropic drugs - A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association [J].

Gutgesell, H ;

Atkins, D ;

Barst, R ;

Buck, M ;

Franklin, W ;

Humes, R ;

Ringel, R ;

Shaddy, R ;

Taubert, KA .

CIRCULATION, 1999, 99 (07) :979-982

[5] The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers [J].

Kessler, RC ;

Adler, L ;

Ames, M ;

Barkley, RA ;

Birnbaum, H ;

Greenberg, P ;

Johnston, JA ;

Spencer, T ;

Üstün, TB .

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2005, 47 (06) :565-572

[6]

NEWCORN JH, 2008, PSYCHIATRY

[7]

O'Keefe L, 2008, AAP NEWS, V29, P1

[8] Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder [J].

Perrin, James M. ;

Friedman, Richard A. ;

Knilans, Timothy K. .

PEDIATRICS, 2008, 122 (02) :451-453

[9]

*US FDA, PED ADV COMM REP

[10]

*US FDA, DRUG SAF RISK MAN AD

← 1 2 →